CN102161991B - 一链多靶干扰核酸分子及其应用 - Google Patents
一链多靶干扰核酸分子及其应用 Download PDFInfo
- Publication number
- CN102161991B CN102161991B CN 201110056948 CN201110056948A CN102161991B CN 102161991 B CN102161991 B CN 102161991B CN 201110056948 CN201110056948 CN 201110056948 CN 201110056948 A CN201110056948 A CN 201110056948A CN 102161991 B CN102161991 B CN 102161991B
- Authority
- CN
- China
- Prior art keywords
- nucleic acid
- acid molecule
- rna
- strand
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (2)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110056948 CN102161991B (zh) | 2011-03-10 | 2011-03-10 | 一链多靶干扰核酸分子及其应用 |
US13/415,600 US9115167B2 (en) | 2011-03-10 | 2012-03-08 | Multi-targets interfering RNA molecules and their applications |
US14/805,746 US10443057B2 (en) | 2011-03-10 | 2015-07-22 | Multi-targets interfering RNA molecules and their applications |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110056948 CN102161991B (zh) | 2011-03-10 | 2011-03-10 | 一链多靶干扰核酸分子及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102161991A CN102161991A (zh) | 2011-08-24 |
CN102161991B true CN102161991B (zh) | 2013-05-29 |
Family
ID=44463444
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201110056948 Active CN102161991B (zh) | 2011-03-10 | 2011-03-10 | 一链多靶干扰核酸分子及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102161991B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103695420A (zh) * | 2013-11-07 | 2014-04-02 | 首都儿科研究所 | 双链siRNA分子及其应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101048505A (zh) * | 2004-10-25 | 2007-10-03 | 德福根有限公司 | 用于递送双链rna至有害生物的包含至少一个适配子的多结构域rna分子 |
-
2011
- 2011-03-10 CN CN 201110056948 patent/CN102161991B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101048505A (zh) * | 2004-10-25 | 2007-10-03 | 德福根有限公司 | 用于递送双链rna至有害生物的包含至少一个适配子的多结构域rna分子 |
Non-Patent Citations (1)
Title |
---|
梁永刚.RNAi非特异效应的干扰素反应探讨.《中国肺癌杂志》.2009,第12卷(第1期),16-22页. * |
Also Published As
Publication number | Publication date |
---|---|
CN102161991A (zh) | 2011-08-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3236976B1 (en) | Rna interference agents for p21 gene modulation | |
Stenvang et al. | MicroRNAs as targets for antisense-based therapeutics | |
US8691965B2 (en) | Oligonucleotides for modulating target RNA activity | |
US8318921B2 (en) | Triggered RNAi | |
Kumar et al. | Delivery and targeting of miRNAs for treating liver fibrosis | |
CN103555722A (zh) | 利用不对称双链rna特异性抑制kras的方法和组合物 | |
JP2014506789A (ja) | miR−124の合成模倣体 | |
US10612020B2 (en) | Artificial mimic miRNA for controlling gene expression, and use of same | |
WO2008094516A2 (en) | Multi-targeting short interfering rnas | |
JP2017511694A (ja) | マイクロrna阻害剤を使用するための組成物および方法 | |
CN108929870B (zh) | 抑制HBV的siRNA分子及其应用 | |
Tan et al. | MicroRNA-based therapy in pain medicine: Current progress and future prospects | |
Lam et al. | Introduction of guanidinium-modified deoxyuridine into the substrate binding regions of DNAzyme 10–23 to enhance target affinity: implications for DNAzyme design | |
CN102191246B (zh) | 多靶标干扰核酸分子及其应用 | |
EP2774989B1 (en) | Double-stranded nucleic acid molecule for gene expression control | |
JP2024518546A (ja) | 修飾されたmRNA、修飾された非コードRNA、およびその使用 | |
CN102161991B (zh) | 一链多靶干扰核酸分子及其应用 | |
Piwecka et al. | Nucleic acid-based technologies in therapy of malignant gliomas | |
US20230129651A1 (en) | Hairpin structure nucleic acid molecules capable of modulating target gene expression and uses thereof | |
CN102199603B (zh) | 多靶位干扰rna分子及其应用 | |
CN102174520B (zh) | 一种干扰核酸分子及应用 | |
CN102140471B (zh) | 一种抑制肿瘤生长的寡聚核酸及其应用 | |
WO2011010737A1 (ja) | マイクロrna切断用のガイド核酸 | |
CN115927304A (zh) | 基于SARS-CoV-2RNA序列的新型siRNA及其应用 | |
ES2764699T3 (es) | Molécula de miARN definida por su fuente y sus usos diagnósticos y terapéuticos en enfermedades o afecciones asociadas a la TEM |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: BAIAO KECHUANG INSTITUTE OF MOLECULAR MEDICINE (NA Free format text: FORMER OWNER: BIOMICS BIOTECHNOLOGIES CO., LTD. Effective date: 20140926 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20140926 Address after: 226016 Jiangsu city of Nantong Province Economic and Technological Development Zone No. 76 Chang Xing Lu Patentee after: Biomics Branch Institute of molecular medicine (Nantong) Co., Ltd. Address before: 226016 Jiangsu city of Nantong Province Economic and Technological Development Zone No. 76 Chang Xing Lu Patentee before: Biomics Biotechnologies Co., Ltd. |
|
C56 | Change in the name or address of the patentee | ||
CP01 | Change in the name or title of a patent holder |
Address after: 226016 Jiangsu city of Nantong Province Economic and Technological Development Zone No. 76 Chang Xing Lu Patentee after: Study on molecular medicine 100 Kechuang source (Nantong) Co., Ltd. Address before: 226016 Jiangsu city of Nantong Province Economic and Technological Development Zone No. 76 Chang Xing Lu Patentee before: Biomics Branch Institute of molecular medicine (Nantong) Co., Ltd. |